REFERENCES
- Bamigboye, E. A. & Familusi, J. B. (1990a). Morbidity trend at the children's emergency room University College Hospital, Ibadan, Nigeria. African Journal of Medicine and Medical Sciences, 19, 49–56.
- Bamigboye, E. A. & Familusi, J. B. (1990b). Mortality pattern at a children's emergency ward University College Hospital, Ibadan, Nigeria. African Journal of Medicine and Medical Sciences, 19, 127–132.
- Ekanem, O. J., Weisfeld, J. S., Salako, L. A., Nahlen, B. L., Ezedinachi, E. N. U., Walker, O., Breman, J. G., Laoye, O. J. & Hedberg, K. (1990). Sensitivity of P. falciparum to chloroquine and sulphadoxine-pyrimethamine in Nigerian children. Bulletin of the World Health Organization, 68, 45–52.
- Harinasuta, T., Bunnag, D. & Wernsdorfer, W. H. (1983). A phase II clinical trial of mefloquine in patients with chloroquine resistant falciparum malaria in Thailand. Bulletin of the World Health Organization, 61, 229–305.
- Hatton, C., Peto, T., Bunch, C., Pasvol, G., Russell, S., Singer, C., Edwards, G. & Winstanley, P. (1986). Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet, i, 411–413.
- Hendrickse, R. G., Hasan, A. H., Olumide, L. O. & Akinkunmi, A. (1971). Malaria in early childhood. An investigation of five hundred seriously ill children in whom a diagnosis of malaria was made on admission to the University College Hospital, Ibadan. Annals of Tropical Medicine and Parasitology, 65, 1–20.
- Matteelli, A., Haji, H., Issa, S., Mohamed, K. & Muchi, J. (1990). In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and sulfadoxine/pyrimethamine, Zanzibar, United Republic of Tanzania. WHO/MAL/90.1055.
- Oduola, A. M. J., Milhous, W. K., Salako, L. A., Walker, O. & Desjardins, R. E. (1987). Reduced in-vitro susceptability to mefloquine in West African isolates of P. falciparum. Lancet, ii, 1304–1305.
- Olatunde, A., Salako, L. A. & Walker, O. (1981). The in-vivo sensitivity of P. falciparum to chloroquine and sulphadoxine-pyrimethamine combination in Ibadan, Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 75, 848–850.
- Salako, L. A. & Aderounmu, A. F. (1987). In-vitro chloroquine and mefloquine resistant Plasmodium falciparum in Nigeria. Lancet, i, 572–573.
- Salako, L. A., Ajayi, F. O., Sowunmi, A. & Walker, O. (1990). Malaria in Nigeria: a revisit. Annals of Tropical Medicine and Parasitology, 84, 435–445.
- Salako, L. A., Sowunmi, A. & Laoye, O. J. (1988). Evaluation of the sensitivity in-vivo and in-vitro of P. falciparum to quinine in an area of full sensitivity to chloroquine. Transactions of the Royal Society of Tropical Medicine and Hygiene, 82, 366–368.
- Spencer, H. C., Oloo, A. J., Watkins, W. W., Sixsmith, D. G., Churchill, F. C. & Koech, D. K. (1984). Amodiaquine more effective than chloroquine against P. falciparum on Kenya coast. Lancet, i, 950–957.
- Sowunmi, A., Salako, L. A., Walker, O & Ogundahunsi, O. A. T. (1990). Clinical efficacy of mefloquine in children suffering from chloroquine resistant falciparum malaria in Nigeria. Transactions of the Royal Socieity of Tropical Medicine and Hygiene, 84, 761–764.
- Walker, O., Salako, L. A., Obih, P. O., Bademosi, K. & Sodeinde, O. (1984). The sensitivity of P. falciparum to chloroquine and amodiaquine in Ibadan, Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 78, 782–784.
- Watkins, W. W., Sixsmith, D. G., Spencer, H. C., Boriga, D. A., Kariuki, D. A., Kipingor, T. & Koech, D. K. (1984). Effectiveness of amodiaquine as treatment for chloroquine resistant P. falciparum infections in Kenya. Lancet, i, 357–359.
- White, N. J., Looareesuwan, S., Warrell, D. A., Warrell, M. J., Bunnag, D. & Harinasuta T. (1982). Quinine pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria. American Journal of Medicine, 73, 564–572.
- World Health Organization (1973). Chemotherapy of Malaria and Resistance to Antimalarials. Technical Report Series No. 529. Geneva: World Health Organization.
- World Health Organization (1984). Advances in Malaria Chemotherapy. Report of a Scientific Group. Technical Report Series No. 711. Geneva: World Health Organization.